Trial · NCT03185481
Results by group81
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 81
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Electrocardiogram Data Meeting Pre-defined Criteria | PF-06649751 15 mg | QTcF Interval (aggregate) >= 500 msec | 0 | Participants | |
| Number of Participants With Worsening Suicidality and New Onset Suicidality | PF-06649751 15 mg | New Onset | 0 | Participants | |
| Number of Participants With Worsening Suicidality and New Onset Suicidality | PF-06649751 15 mg | Worsening | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Anxiety, Nervousness / Not Present | 3 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Anxiety, Nervousness / Mild | 1 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Anxiety, Nervousness / Moderate | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Anxiety, Nervousness / Severe | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Difficult Concentrating, Remembering / Not Present | 3 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Difficult Concentrating, Remembering / Mild | 1 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Difficult Concentrating, Remembering / Moderate | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Difficult Concentrating, Remembering / Severe | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Dysphoric Mood, Depression / Not Present | 3 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Dysphoric Mood, Depression / Mild | 1 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Dysphoric Mood, Depression / Moderate | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Dysphoric Mood, Depression / Severe | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Fatigue, Lethargy, Lack of Energy / Not Present | 2 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Fatigue, Lethargy, Lack of Energy / Mild | 1 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Fatigue, Lethargy, Lack of Energy / Moderate | 1 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Fatigue, Lethargy, Lack of Energy / Severe | 0 | Participants | |
| Number of Participants With Benzodiazepine Discontinuation Symptoms Based on Physician Withdrawal Checklist (PWC-20) | PF-06649751 15 mg | Insomnia / Not Present | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03185481/results?page=2